Board
AlphaNet, Inc. was founded in 1995 by 3 Alphas and according to our bylaws at least 50% of our board members must be either diagnosed with Alpha-1, known carriers of the gene for Alpha-1, or the spouse, child, or parent of a person diagnosed with Alpha-1. Our Board of Directors is focused on the provision of comprehensive health management services to individuals affected by Alpha-1, which includes contributing toward the advancement of clinical research, public and patient education, and health management.
Board Officers
Dell Witcher
Chair
Vestavia Hills, AL
Miekeleen Hart
Vice Chair
Akron, OH
Diana Patterson
Treasurer
Colfax, LA
Grant Wood
Secretary
Salt Lake City, UT
Robert Greene, Jr.
Immediate Past Chair
Wyoming, MI
Board Members
Mark Delvaux
President and Chief Executive Officer
Coral Gables, FL
Charles "Tim" Frost
Member
Vienna, VA
Albert Garcia
Board Member
Miami, FL
David Pusey
Member
Fort Collins, CO
Robert Sandhaus, MD, PhD, FCCP
Senior Medical Director and Executive VP
Bow Mar, CO
Staff
Our corporate staff enables us to meet our mission of improving the lives of individuals affected by Alpha-1 Antitrypsin Deficiency.
Corporate Staff
Mark Delvaux
President and Chief Executive Officer
Christine Lanser Yllanes
Vice President of Marketing & Strategic Engagement
Victoria Vaccaro
Director of Human Resources
Christopher Williams
Director of Finance
Carol Morse
Director of Strategy Implementation
Veronika Dosseva
Controller
Christen Chacon
Digital Marketing Manager
Sheri Allison
IT Manager
Terri Schroth
IT Business Analyst
Christopher Pruna
IT Security and Operations Administrator
Curtis Christensen
IT Network Administrator
Natalie Gonzalez
Communications Coordinator
Kelly Reyes
Payroll Administrator
Kristopher Quintero
AP/AR Coordinator
Paul Kludt
Special Projects Manager
Coordinators
Each AlphaNet Coordinator has Alpha-1 Antitrypsin Deficiency and, thus, is able to uniquely understand the issues and concerns of other individuals living with Alpha-1. AlphaNet Coordinators are spread across the United States and subscribers to AlphaNet are assigned to a specific AlphaNet Coordinator based on the augmentation therapy prescribed and their geographic location.